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Abstract: Objective: It is a common belief that menopausal women have greater difficulty losing
weight. The aim of this study was to assess the efficacy of a Mediterranean diet (MD) to promote
weight loss in postmenopausal women. All participants were prescribed a hypocaloric traditional
MD, tailored to the individual. Subjects were asked not to begin any kind of physical activity.
Body composition was measured at the beginning and after 8 weeks of treatment. In total, 89 women
(age 52.8 ± 4.5 years, BMI 30.0 ± 5.2 kg/m2, fat mass 31.6 ± 10.5 kg) were divided into two groups:
the first group consisted of fertile women over 45 years of age, the second group consisted of
those diagnosed as menopausal. All women had an improvement in body composition (fat mass
−2.3 ± 2.1 kg, p < 0.001; protein −0.1 ± 0.7 kg, p = 0.190) and blood pressure values. No differences
were found between the two groups except for a higher reduction of low-density lipoprotein in the
menopausal group (p = 0.035). A positive significant correlation between plant to animal protein
ratio and fat-free mass variation was found in the menopausal group. These data suggest that a high
adherence to a traditional MD would enable menopausal women to lose fat mass and maintain muscle
mass with no significant difference to younger women. Fat mass reduction provides menopausal
women with improved cardiovascular and metabolic risk factors.
Keywords: Mediterranean diet; body composition; menopause; weight loss; chronic degenerative diseases
1. Introduction
Menopause is a period in a woman’s life when weight maintenance may be particularly difficult [1].
Obesity is more common in men than in women before 45 years of age, but, after this point, the trend
reverses [2]. It is estimated that women gain an average of 1–2 kg during the perimenopausal
transition [3,4]. During the menopause, there is a shift in fat distribution and storage from the hips
to the waist. There are a number of hormonal changes, such as decreased levels of estrogen and
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increased levels of circulating androgens, that lead to weight gain, particularly in terms of visceral
fat [5]. In consequence, visceral fat mass increases by 44% during menopause, and the mass of gynoid
fat rises by approximately 32% [6].
In addition to hormonal variations, it is relevant to consider the contribution of environmental
factors such as reduced physical activity, Westernized eating patterns and common emotional eating
disorders related to psychological discomfort [7]. Thus, various lipid metabolic disorders may lead to
the development of metabolic syndromes including cardiovascular diseases and type 2 diabetes [8].
For this reason, metabolic syndrome is found in menopausal women three times more often than before
the menopause [5]. This increased risk seems to be caused more by changes during the menopausal
transition than by postmenopause [9].
Proper nutrition plays a fundamental role in the prevention of chronic degenerative diseases
during the menopause [10]. In a study of women aged 50 to 60 years, fruit, vegetables and wholemeal
bread were the most frequently consumed products in the healthy diet group. Significant correlations
were observed with mental health, functioning in society, emotionality, vitality and well-being [11].
However, modest associations were observed for some single nutrients or food items with ovarian
reserve and age at menopause [12]. Dietary intervention plus exercise provided better body weight
and body composition (BC) parameters than calorie-restricted diet interventions alone in overweight
and obese peri- and postmenopausal women [13].
Few studies have compared the efficacy of diet therapies in promoting weight loss in
postmenopausal women [14]. The aim of this study is to assess whether menopausal status affects
weight loss and BC changes in a homogeneous group of women over 45 years of age undergoing a
traditional Mediterranean-type low-calorie diet.
2. Materials and Methods
2.1. Subjects
Subjects were selected from those who attended a nutrition clinic in Rome, Italy for the first time
during the last trimester of 2019. All participants referred to the center were motivated to lose weight
and were not informed of the different study groups within the study once they had agreed to take
part. The criteria for eligibility were an age of 45 or more, a body mass index (BMI, the weight in
kilograms divided by the square of the height in meters) of at least 25 kg·m−2 but less than 45 kg·m−2,
a stable body weight over the 2 months before the baseline, and no change in medication for at least
3 months. Exclusion criteria were as follows: pregnancy or nursing; diabetes mellitus; chronic kidney
disease; glucocorticoids, estrogens and anti-convulsant therapies; history of cardiovascular, neoplastic
or other systemic diseases (both chronic and acute); any medication use known to affect weight/energy
expenditure; alcohol intake (more than 3 drinks/day). The study was approved by the Ethics Committee
of the University Hospital “Tor Vergata” (ID number 41.17) and all subjects gave informed consent.
The study was conducted in accordance with the Declaration of Helsinki.
2.2. First Visit
All participants underwent a comprehensive medical evaluation including a clinical history,
physical examination and anthropometric parameter measurement with BC assessment, blood pressure
measurement and a blood sample. Blood pressure was measured after at least 10 min of rest in the
sitting position, with a standard mercury sphygmomanometer on both arms. For all factors, mean data
were determined from two measurements, and mean results were reported.
2.3. Body Composition Assessment
Weight and height were measured after an overnight fast. During the measurements, the subjects
were allowed to wear only underwear. BMI was calculated as weight (kg) divided by the square of the
height (m2). A standard cloth tape measure was used to record waist (WC) and hip (HC) circumferences.
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WC was taken at the midpoint between the lateral iliac crest and the lowest rib. HC was measured
at the widest portion of the buttocks. BC was recorded with a BIA Tanita BC-420 MA, a validated
instrument that uses dual-X-ray absorptiometry (DXA) [15] and measures values from a standing
position and without the use of electrodes, to within 100 g. Patients were required to observe the
following guidelines before BC evaluation: testing to be performed 3 h or more after meals and at least
3 h after waking up; no alcohol to be consumed and no severe restriction of caloric intake within 48 h
of testing; no diuretics to be used within 7 days of testing and 12 h or more after hard, high intensity
physical activity; urination just before testing; testing to avoid the menstruation period. Fat mass (FM),
fat-free mass (FFM), protein and hydration status (total body water, TBW) were considered.
2.4. Dietary Intervention
All participants were placed on a two-month hypocaloric nutritionally balanced diet tailored to
the individual. The moderate-fat, restricted-calorie Mediterranean diet (MD) was elaborated using
nutritional software (Winfood 2.8; Medimatica Srl, Martinsicuro, Italy).
The main features of the prescribed diet were similar to the traditional Italian Nicotera’s MD [16].
This is a diet rich in plant-based foods such as fruits and vegetables, legumes and whole grains.
The various components, expressed as percentages of the total calorie intake, were cereals 50–59%,
extra virgin olive oil 13–17%, vegetables 2.2–3.6%, potatoes 2.3–3.6%, legumes 3–6%, fruit 2.6–3.6%,
fish 1.6–2%, red wine 1–6%, meat 2.6–5%, dairy products 2–4% and very low amounts of eggs and
animal fats. Patients were asked to use herbs and spices instead of salt to flavor foods, to reduce red
meat to no more than twice a week and to eat fish at least twice a week. The main sources of daily
added fat were 25 to 35 g of olive oil and a handful of nuts (20 g) per day.
The recommended composition of the dietary regimen was as follows: carbohydrates 50–60%,
proteins 10–15% (of which more than 50% should be comprised of vegetable proteins), total fat less than
30% (saturated fat less than 7% and cholesterol consumption less than 300 mg per day), and more than
30 g of fiber. Diets were divided into three main meals and two snacks, with a 500–600 kcal/day deficit
compared to the estimated total energy expenditure TEE [17]. The after-dinner snack was prescribed
only when requested.
It was recommended that patients only performed minimal aerobic training.
2.5. Dietary Intake
Patients were required to record their dietary intake (consecutively over two weekdays and one
weekend day) in a semi-quantitative weighed food record at baseline, and then weekly throughout the
follow-up. To avoid under-reporting, all subjects whose reported intake was <110% of their estimated
basal metabolic rate were excluded, as explained by Mendez et al. [18]. Subjects were required to
weigh and measure their food using home digital scales. Dietary composition was examined using
professional software (Nutritics, Dublin, Ireland, 2019).
2.6. Follow-Up Visits
The same parameters described above were measured after 4 and 8 weeks. Results after 8 weeks
were compared with those of the baseline tests. This involved individual sessions (anthropometric, BC,
evaluation of nutrient intake and diet adequacy). Thus, twice a month, patients were scheduled to meet
the dietitian to reinforce the nutritional rehabilitation program that aimed to improve and promote
changes in eating habits. Tables with nutritional values of foods were used to assist participants with
grocery shopping. A web chat consultation service was also provided to families and the health care
professionals caring for them, for patient support.
2.7. Laboratory Data
In a group of 30 patients, hematochemical tests were required. Blood samples were taken in the
morning (between 7:00 AM and 9:00 AM). Total cholesterol, high-density lipoprotein (HDL) cholesterol
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and triglycerides were determined by automated conventional enzymatic methods. Low-density
lipoprotein (LDL) cholesterol was calculated using Friedewald’s formula [19]. Serum levels of 25(OH)D
and fasting insulin were determined by chemiluminescence. The hematochemical values were repeated
at the end of the study, except for vitamin D which was only determined at the beginning.
2.8. Groups
The patients were separated into two groups. The first group (REGULAR) contained women over
45 years old with a regular menstrual cycle; the second group (MENOPAUSE) contained women in
menopause. Menopause was defined as a woman’s FSH blood level being consistently elevated to
30 mIU/mL or higher and no menstrual period for a year.
2.9. Statistical Analysis
The data were analyzed with SOFA Statistics version 1.4.6 open source software. Results for
descriptive statistics are expressed as mean ± standard deviation. All quantitative variables were tested
for normality distribution using the Kolmogorov–Smirnov test. Dietary composition data (energy
intake; percentage of carbohydrate, fat and protein; g saturated fat and fibre) were analyzed using
means. Baseline differences in continuous variables between the groups’ subjects were assessed with
Student’s t-test for unpaired data. Statistical comparisons of continuous variables among the groups
were performed with independent sample t-tests. The relationship between age and menopause
duration and BC parameter variations was evaluated. The Spearman’s coefficient was used to measure
the correlation among variables and the corresponding p-values are reported for the significance
of the correlation. For all analyses, a p-value < 0.05 based on a two-sided test was considered
statistically significant.
3. Results
Baseline features of the 89 women recruited for the study (age 52.8 ± 4.5 years, 17 smokers) are
shown in Table 1. One subject dropped out due to personal reasons. All subjects were white Europeans.
Subjects had an average BMI of 30.0 ± 5.2 kg/m2, FM of 31.6 ± 10.5 kg, FFM of 45.0 ± 5.3 kg and TBW
of 33.5 ± 4.6 kg. All participants were overweight or obese, with nearly 45% of the subjects recording a
BMI over 30 and predominant abdominal obesity according to WC measurements (94.8 ± 13.6 cm).
Hypertension was reported in 30 subjects. There were no significant differences between the two
groups apart from the menopausal women having a significantly higher systolic blood pressure (SBP).
Table 1. Body composition and other characteristics of study subjects.
Variables Menopause(n. 43)
Regular
(n. 46)
Total
(n. 89)
Between-Group
p-Value
Age 57.1 ± 4.9 48.8 ± 4.0 52.8 ± 4.5 <0.001
Smokers 11 6 17
Height, m 162.4 ± 5.7 161.6 ± 6.4 162.0 ± 6.1 0.536
Weight, kg 80.8 ± 16.2 77.0 ± 14.1 78.8 ± 15.2 0.240
BMI, kg/m2 30.6 ± 5.4 29.5 ± 5.0 30.0 ± 5.2 0.321
Waist, cm 97.5 ± 15.3 92.2 ± 11.5 94.8 ± 13.6 0.067
Hip, cm 109.5 ± 9.8 108.2 ± 9.4 108.8 ± 9.6 0.525
BMR, kcal/day 1449.5 ± 190.0 1428.8 ± 179.0 1438.8 ± 183.6 0.598
SBP, mm Hg 133.8 ± 17.2 124.6 ± 13.3 129.0 ± 15.9 0.005
DBP, mm Hg 85.2 ± 13.0 80.6 ± 12.8 82.8 ± 13.0 0.096
Body Composition
FM, kg 33.4 ± 11.1 29.9 ± 9.7 31.6 ± 10.5 0.116
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Table 1. Cont.
Variables Menopause(n. 43)
Regular
(n. 46)
Total
(n. 89)
Between-Group
p-Value
FFM, kg 45.1 ± 5.4 44.9 ± 5.3 45.0 ± 5.3 0.860
TBW, kg 33.6 ± 4.8 33.4 ± 4.4 33.5 ± 4.6 0.838
Body protein, kg 11.5 ± 0.8 11.5 ± 1.0 11.5 ± 0.9 1.000
Haematochemical tests *
Menopause
(n. 15)
Regular
(n. 15)
Total
(n. 30)
Between-Group
p-Value
Glycaemia, mg/dL 92.7 ± 14.0 92.4 ± 9.4 92.6 ± 11.9 0.946
Total cholesterol, mg/dL 219.6 ± 41.7 202.9 ± 35.5 210.8 ± 39.2 0.248
LDL, mg/dL 143.6 ± 36.2 130.3 ± 29.4 136.9 ± 33.3 0.279
HDL, mg/dL 58.3 ± 12.6 58.9 ± 16.4 58.6 ± 14.7 0.911
Triglycerides, mg/dL 108.3 ± 65.2 92.0 ± 39.0 99.8 ± 53.4 0.413
Vitamin D3, ng/mL 22.4 ± 8.2 19.2 ± 12.4 20.9 ± 10.3 0.407
* Data of 30 patients. Data are expressed as mean values ± SD. Abbreviations—SD: standard deviation; n: number
of subjects; ns: not significant; BMI: body mass index; LDL: low-density lipoprotein; HDL: high-density lipoprotein;
FM: fat mass; FFM: fat-free mass; TBW: total body water; BMR: basal metabolic rate; SBP: systolic blood pressure;
DBP: diastolic blood pressure.
The composition of the dietary intake and the difference between groups are shown in Table 2.
Analysis of the food diaries shows that the diets had a mean macronutrient composition of about
0.85 g/kg/day protein, 32% fat and 52% carbohydrates, with three main meals and two snacks spread
throughout the day.
Table 2. Composition and % breakdown of meals of the basal dietary intake and differences
between groups.
Variables Menopause(n. 43)
Regular
(n. 46)
Total
(n. 89)
Between-Group
p-Value
Calories, kcal 1456.3 ± 126.4 1453.5 ± 157.5 1454.9 ± 142.5 0.927
Carbohydrates, % 52.8 ± 3.1 51.9 ± 4.0 52.3 ± 3.6 0.257
Protein, % 17.5 ± 1.0 17.5 ± 1.2 17.5 ± 1.1 0.970
Lipids, % 32.2 ± 2.8 32.7 ± 3.4 32.5 ± 3.1 0.430
Carbohydrates, g 192.1 ± 17.9 188.7 ± 24.7 190.3 ± 21.6 0.462
Oligosaccharides, g 74.5 ± 9.2 71.3 ± 8.4 72.9 ± 8.9 0.090
Starch, g 98 ± 17.1 97 ± 17.1 97.5 ± 17 0.783
Total fiber, g 40.9 ± 3.3 41.3 ± 4.1 41.1 ± 3.7 0.615
Insoluble fiber, g 19.1 ± 1.7 19.2 ± 1.4 19.2 ± 1.5 0.762
Soluble fiber, g 6.7 ± 0.7 6.6 ± 0.8 6.7 ± 0.7 0.533
Protein, g 63.6 ± 5.9 63.3 ± 6.5 63.5 ± 6.2 0.821
Protein, g/kg 0.81 ± 0.14 0.84 ± 0.13 0.82 ± 0.13 0.257
Plant protein, g 36.9 ± 4.8 36.9 ± 3.8 36.9 ± 4.3 1.000
Animal protein, g 18.1 ± 4.8 17.3 ± 5.4 17.7 ± 5.1 0.463
Plant to animal protein ratio 2.1 ± 0.5 2.3 ± 0.8 2.2 ± 0.6 0.190
Lipids, g 52.2 ± 7.6 53 ± 8.7 52.6 ± 8.1 0.646
TUFA, g 35.7 ± 5.4 36.1 ± 6.1 35.9 ± 5.7 0.745
MUFA, g 26.9 ± 4 27.1 ± 4.7 27 ± 4.4 0.830
PUFA, g 8.8 ± 1.6 9 ± 1.8 8.9 ± 1.7 0.582
SFA, g 9.3 ± 1.6 9.2 ± 2 9.2 ± 1.8 0.796
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Table 2. Cont.
Variables Menopause(n. 43)
Regular
(n. 46)
Total
(n. 89)
Between-Group
p-Value
Cholesterol, mg 77.9 ± 26.8 73.8 ± 29.3 75.7 ± 28.1 0.494
Alcohol, g 0 1.5 ± 6 0.8 ± 4.4 0.105
% BREAKDOWN AMONG MEALS (calories)
Breakfast, % 18.3 ± 3 18.2 ± 3.6 18.2 ± 3.3 0.888
Morning Snack, % 9.2 ± 6.9 9.8 ± 8.6 9.5 ± 7.8 0.719
Lunch, % 30.5 ± 6.3 31.6 ± 8.4 31.1 ± 7.4 0.489
Afternoon Snack, % 12.3 ± 6.4 11.8 ± 6.8 12 ± 6.6 0.722
Dinner, % 28.9 ± 7.4 27.8 ± 7.4 28.3 ± 7.4 0.485
After Dinner, % 4.6 ± 3.3 5.6 ± 2.7 5.1 ± 3 0.120
Data are expressed as mean values ± SD. Abbreviations—n: number of subjects; TUFA: total unsaturated fatty acids;
SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids.
The differences for all subjects after 2 months are shown in Table 3. Analysis of the results of the
entire sample, two months after the start of nutritional therapy, shows a significant difference in BMI
of −0.8 ± 0.5 kg/m2, FM of −2.3 ± 2.1 kg and FFM of −0.7 ± 1.6 kg, of which TBW was −0.6 ± 1.1 kg
and body protein was −0.1 ± 0.7 kg (p = 0.190). No significant correlation is observed between patients’
age and BC variation during treatment (Figure 1). The change in lifestyle also brought a significant
improvement in body circumference and blood pressure. The variation in basal metabolic rate (BMR)
was −25.6 ± 38.3 kcal/day. The weight loss allowed a significant improvement of some lipid blood
values, such as total cholesterol and LDL, in the whole sample.
Table 3. Changes in parameters for study subjects between baseline and 2-month follow-up.
Variables TOTAL (n. 89) Total Samplep-Value
MENOPAUSE
(n. 43)
REGULAR
(n. 46)
Between-Group
p-Value
4Weight, kg −3.4 ± 2.3 <0.001 −3.7 ± 2.6 −3.1 ± 1.9 0.215
4 BMI, kg/m2 −0.8 ± 0.5 <0.001 −0.9 ± 0.5 −0.8 ± 0.5 0.348
4 FM, kg −2.3 ± 2.1 <0.001 −2.4 ± 2.0 −2.2 ± 2.1 0.647
4 FFM, kg −0.7 ± 1.6 <0.001 −0.6 ± 1.6 −0.8 ± 1.6 0.557
4 TBW, kg −0.6 ± 1.1 <0.001 −0.5 ± 1.1 −0.6 ± 1.2 0.684
4 Body protein, kg −0.1 ± 0.7 0.190 −0.1 ± 0.8 −0.1 ± 0.5 1.000
4Waist, cm −3.1 ± 2.9 <0.001 −3.1 ± 3.1 −3.2 ± 2.8 0.873
4 Hip, cm −2.8 ± 2.6 <0.001 −2.6 ± 2.9 −3.0 ± 2.3 0.471
4 BMR, Kcal −25.6 ± 38.3 <0.001 −24.1 ± 40.2 −27 ± 36.9 0.724
4 SBP, mm Hg −7.9 ± 15.2 <0.001 −9 ± 16.4 −6.8 ± 13.9 0.496
4 DBP, mm Hg −5.1 ± 13.2 0.014 −7 ± 14.9 −3.3 ± 11.2 0.187
Haematochemical tests *
TOTAL (n. 30) Total Samplep-Value
MENOPAUSE
(n. 15)
REGULAR
(n. 15)
Between-Group
p-Value
4 Glycaemia, mg/dL −2.3 ± 9.1 0.193 −2.5 ± 10.1 −2.2 ± 7.9 0.928
4 Triglycerides, mg/dL −6.3 ± 48 0.493 −22.9 ± 56.2 8.2 ± 35.1 0.080
4 Total cholesterol,
mg/dL −15.3 ± 28.2 0.033 −22.8 ± 24.7 −9.3 ± 29.9 0.188
4 HDL, mg/dL 3.9 ± 10.5 0.059 6.0 ± 10.4 2.2 ± 10.6 0.330
4 LDL, mg/dL −17.2 ± 26.4 0.028 −28.2 ± 31.6 −7.7 ± 16.9 0.035
Data are expressed as mean values ± SD. Abbreviations—n: number of subjects; BMI: body mass index; LDL:
low-density lipoprotein; HDL: high-density lipoprotein; FM: fat mass; FFM: fat-free mass; TBW: total body water;
BMR: basal metabolic rate; SBP: systolic blood pressure; DBP: diastolic blood pressure. * Data of 30 patients.
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body mass and more than double their FM, and that this trend continues until 2 years after 
menopause when the BC stabilizes [3,6,7,20]. This phenomena is influenced more by reduced energy 
expenditure rather than increased energy intake [21]. Our data confirm other work which showed 
that a higher adherence to a healthy dietary pattern (the Mediterranean diet) is inversely associated 
with overweight/obesity in perimenopausal and postmenopausal women [22]. 
A cross-sectional study by Rolland et al. showed a decline of 0.6% per year in muscle mass after 
menopause [23]. The same study showed that, for an increase of 0.1 g/kg of daily protein intake, the 
drop in muscle mass was reduced by 0.62 kg. Our data revealed that a protein intake similar to the 
nutritional guidelines (0.82 g/kg) was enough to lose FM and maintain muscle mass in menopause 
patients. On the other hand, a recent review has found that intake exceeding the Recommended Daily 
Allowance (RDA) may be preferential in preserving muscle mass and function in ageing adults [24]. 
For instance, among post-menopausal women of 60-90 years, those in the low protein group had 
higher body fat and fat-to-lean ratio than those who consumed a higher protein diet [25]. 
Figure 3. Correlation between plant to animal protein ratio and FFM (A) and body protein (B) variation
in the MENOPAUSE group after the lifestyle intervention.
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The composition of the basal diets and the difference between groups are shown in Table 2.
Analysis of the food diaries shows that the diets had a mean macronutrient composition of about 12%
proteins (0.85 gr/kg/day), 32% fat and 56% carbohydrates. Throughout the day were three main meals
and two snacks. The after-dinner snack was prescribed only for women requesting it.
The differences for all subjects after 2 months are shown in Table 3. Analysis of the results of the
entire sample, two months after the start of nutritional therapy, shows a significant difference of BMI of
−0.8 ± 0.5 kg/m2, FM of −2.3 ± 2.1 kg, FFM of −0.7 ± 1.6 kg of which TBW was −0.6 ± 1.1 and protein
−0.1 ± 0.7 (p = 0.1862). The analysis of linear regression between patients’ age and BMI variation during
treatment shows that dietary effectiveness tends to increase slightly with age (r = −0.123; p = 0.252,
Figure 1). The change in lifestyle also brought a significant improvement in body circumference and
blood pressure. The variation in basal metabolic rate (BMR) was −25.6 ± 38.3 kcal/die. The weight
loss allowed a significant improvement of some lipid blood values, such as total cholesterol and LDL,
in the whole sample.
There were no significant differences between the two groups for any of these parameters,
except for the variation of LDL where the reduction was greatest in the group of menopausal women
(−28.2 ± 31.6 mg/dL vs. −7.7 ± 16.9 mg/dL; p = 0.035).
4. Discussion
Overall, we found that high adherence to a traditional MD diet, with moderate protein and
high fiber intake, had a similar effect on BC for free-living postmenopausal overweight/obese women
and fertile women. Several studies have demonstrated that women undergoing perimenopause lose
lean body mass and more than double their FM, and that this trend continues until 2 years after
menopause when the BC stabilizes [3,6,7,20]. This phenomena is influenced more by reduced energy
expenditure rather than increased energy intake [21]. Our data confirm other work which showed that
a higher adherence to a healthy dietary pattern (the Mediterranean diet) is inversely associated with
overweight/obesity in perimenopausal and postmenopausal women [22].
A cross-sectional study by Rolland et al. showed a decline of 0.6% per year in muscle mass after
menopause [23]. The same study showed that, for an increase of 0.1 g/kg of daily protein intake,
the drop in muscle mass was reduced by 0.62 kg. Our data revealed that a protein intake similar to the
nutritional guidelines (0.82 g/kg) was enough to lose FM and maintain muscle mass in menopause
patients. On the other hand, a recent review has found that intake exceeding the Recommended Daily
Allowance (RDA) may be preferential in preserving muscle mass and function in ageing adults [24].
For instance, among post-menopausal women of 60–90 years, those in the low protein group had
higher body fat and fat-to-lean ratio than those who consumed a higher protein diet [25].
Surprisingly, we found a correlation between a higher plant to animal protein ratio and a lower
reduction in lean mass, both in the whole sample (Figure 2) and in the menopausal women group
(Figure 3). Plant-based protein sources have a lower leucine content than animal-based protein
sources. Furthermore, plant-based protein sources are classically considered as “deficient in certain
essential amino acids” for body needs [26]. A previous study showed that higher plant protein
intake, particularly from non-cereal products, with a proportional decrease in animal protein intake
did not affect body weight maintenance or cardiometabolic risk factors [27]. A high protein content
of plant origin, such as the traditional MD, would add further benefits to patients’ health. Other
papers support the beneficial effect of a MD, which is rich in legumes, fiber, and monounsaturated fat,
for weight loss [28,29]. This advantage would add to the other positive effects of consuming this type
of protein in menopause, such as decreasing bone loss and risk of hip fracture [30], improving insulin
sensibility [31,32] and decreasing cardiovascular disease risk [33].
Our data confirm the importance of the MD in menopausal patients for the improvement of
cardiovascular and metabolic risk factors. Patients in the menopausal group had even greater
improvement in LDL and triglyceride parameters. After the menopause, lipid metabolic disorders are
common, mainly due to hormonal changes. It has been demonstrated that a high, but not medium,
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adherence to the MD is associated with a cardioprotective effect in peri and menopausal women [34].
A stronger adherence to a MD was associated with a lower lipid peroxidation (LPO) among healthy
women [35]. LPO is actively involved in the inflammatory responses in atherosclerosis by interacting
with immune cells (such as macrophages) and endothelial cells [36].
In this study, women lost a minimal, non-significant amount of muscle mass, although their
physical activity was reduced and was only of the aerobic type. These findings may indicate that a
hypocaloric MD, without prescription of physical activity, is sufficient to lose FM and preserve FFM in
the short term. However, physical activity may be vital to modify the BC in menopausal women with
obesity in the long term [37]. The slight reduction in resting metabolism shows that the MD may be
an excellent option for maintaining weight loss in the long term [38]. Conflict exists as to whether
perimenopausal weight gain is due to changes in energy metabolism related to aging or changes in
sex hormones related to menopause. Several papers have demonstrated that aging is the primary
driver of FM gain in menopausal women, rather than the constant change of hormone levels during
menopause [39,40]. A reduction in BMR at menopause has been shown to be independent of changes
in BC [41] and may be related to a reduction in the 24-h core temperature [42].
In our study, we found no correlation between age and improvement in BC (Figure 1). Patients had
improvements regardless of their age and the age of menopause. In a previous study, the factors
significantly related to ≥3% weight gain were weight change in the past 2 years, age at menopause,
dietary fiber, fat, alcohol intake, and smoking [42].
Our study had several limitations. Firstly, the sample size was relatively small. Secondly,
the methods for assessing the energy expenditure of BC should have been more precise than those
used. Thirdly, the participants should have been studied for a longer period of time.
5. Conclusions
High adherence to the Mediterranean diet would ensure menopausal women lose fat mass and
maintain muscle mass in the same way as younger women, without the prescription of “structured”
physical activity. Increasing the plant protein content of a hypocaloric diet may lead to a preservation of
muscle mass in menopausal women. Studies demonstrating long-term effects of diets on menopausal
women are warranted.
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